NCATS STTR Phase I
Funds U.S. small businesses and their nonprofit research partners to conduct feasibility studies on translational science innovations toward commercialization.
NCATS STTR Phase I is a six-month feasibility grant for U.S. small businesses working in partnership with a nonprofit research institution (university, hospital, or federal lab). It runs under the NIH SBIR/STTR Omnibus Solicitation — the same grant vehicle used by all NIH institutes — but NCATS selects applicants whose work fits its specific translational science priorities. Awards are normally $3…
Any biomedical or behavioral research area within NCATS's translational science mission: drug discovery, diagnostics, medical devices, informatics, and platform technologies that advance translation of basic research findings to clinical or commercial use. NCATS-specific priorities include rare diseases, toxicology, clinical trial innovation, and translational informatics.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up